Development and validation of a cognitive screening tool in China

Takeaway

  • A modified Chinese version of Mini Addenbrooke’s Cognitive Examination was developed and validated in patients with normal cognition (NC) and mild cognitive impairment (MCI).

Why this matters

  • Brief cognitive screening tests are inexpensive, fast, and non-invasive tools for classifying patients with MCI.

  • The adaption, translation, and validation of these tests is key in the rapid identification of patients with cognitive decline for early intervention.